This novel information regarding the involvement of NE in leukemia cell proliferation and apoptosis may be used to identify a potential biomarker or treatment target for leukemia, and the NE-specific inhibitor GW311616A may be a promising treatment target option. Here, ELANE is linked to leukemia.